Omeros (OMER) Shares Outstanding (Weighted Average) (2010 - 2026)
Omeros recorded quarterly Shares Outstanding (Weighted Average) of $71.9 million in Q1 2026, up 13.24% quarter-over-quarter from $63.5 million in Q4 2025, and up 23.87% year-over-year from $58.1 million in Q1 2025.
Omeros' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $71.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 23.87% year-over-year to $71.9 million; the TTM figure through Mar 2026 stood at $71.9 million (up 23.87% YoY), while the FY2025 annual figure was $63.5 million, up 9.18% from the prior year.
- Shares Outstanding (Weighted Average) came in at $71.9 million for Q1 2026 at Omeros, up from $63.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $71.9 million in Q1 2026 to a low of $200000.0 in Q2 2022.
- A 5-year average of $58.0 million and a median of $62.7 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 31262.39% in 2022 and fell as far as 99.68% in 2022.
- Omeros' Shares Outstanding (Weighted Average) stood at $62.7 million in 2022, then grew by 0.0% to $62.7 million in 2023, then retreated by 7.28% to $58.2 million in 2024, then climbed by 9.18% to $63.5 million in 2025, then climbed by 13.24% to $71.9 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $71.9 million, $63.5 million, and $66.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 71.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.92 Mn |
| Dec 31, 2025 | 63.51 Mn |
| Sep 30, 2025 | 66.26 Mn |
| Jun 30, 2025 | 58.32 Mn |
| Mar 31, 2025 | 58.06 Mn |
| Dec 31, 2024 | 58.17 Mn |
| Sep 30, 2024 | 58.23 Mn |
| Jun 30, 2024 | 57.94 Mn |
| Mar 31, 2024 | 58.80 Mn |
| Dec 31, 2023 | 62.74 Mn |
| Sep 30, 2023 | 62.84 Mn |
| Mar 31, 2023 | 62.83 Mn |
| Dec 31, 2022 | 62.74 Mn |
| Sep 30, 2022 | 62.73 Mn |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 62.72 Mn |
| Dec 31, 2021 | 62.34 Mn |
| Sep 30, 2021 | 62.27 Mn |
| Jun 30, 2021 | 62.15 Mn |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 57.18 Mn |
| Sep 30, 2020 | 55.68 Mn |
| Jun 30, 2020 | 243,115.00 |
| Mar 31, 2020 | 54.30 Mn |
| Dec 31, 2019 | 49.52 Mn |
| Sep 30, 2019 | 43,115.00 |
| Jun 30, 2019 | 49.05 Mn |
| Mar 31, 2019 | 49.01 Mn |
| Dec 31, 2018 | 48.58 Mn |
| Sep 30, 2018 | 48.65 Mn |
| Jun 30, 2018 | 48.38 Mn |
| Mar 31, 2018 | 48.28 Mn |
| Dec 31, 2017 | 45.54 Mn |
| Sep 30, 2017 | 46.26 Mn |
| Jun 30, 2017 | 43.93 Mn |
| Mar 31, 2017 | 43.83 Mn |
| Dec 31, 2016 | 40.45 Mn |
| Sep 30, 2016 | 41.06 Mn |
| Jun 30, 2016 | 39.18 Mn |
| Mar 31, 2016 | 38.32 Mn |
| Dec 31, 2015 | 37.56 Mn |
| Sep 30, 2015 | 1.15 Mn |
| Jun 30, 2015 | 1.15 Mn |
| Mar 31, 2015 | 36.48 Mn |
| Dec 31, 2014 | 33.23 Mn |
| Sep 30, 2014 | 34.01 Mn |
| Jun 30, 2014 | 33.93 Mn |
| Mar 31, 2014 | 30.90 Mn |
| Dec 31, 2013 | 28.56 Mn |
| Sep 30, 2013 | 27.98 Mn |
| Jun 30, 2013 | 28.20 Mn |
| Mar 31, 2013 | 25.91 Mn |
| Dec 31, 2012 | 24.16 Mn |
| Sep 30, 2012 | 25.83 Mn |
| Jun 30, 2012 | 22.45 Mn |
| Mar 31, 2012 | 22.43 Mn |
| Dec 31, 2011 | 22.21 Mn |
| Sep 30, 2011 | 22.25 Mn |
| Jun 30, 2011 | 22.17 Mn |
| Mar 31, 2011 | 22.06 Mn |
| Dec 31, 2010 | 21.42 Mn |
| Sep 30, 2010 | 21.39 Mn |
| Jun 30, 2010 | 21.34 Mn |